Kautzner J, Hartikainen J, Heald S, Malik M, Ward D, Rowland E
Department of Cardiological Sciences, St George's Hospital Medical School, London, United Kingdom.
Pacing Clin Electrophysiol. 1996 Nov;19(11 Pt 2):1993-7. doi: 10.1111/j.1540-8159.1996.tb03268.x.
To assess the potentially adverse effects of RF catheter ablation (RFCA) of the slow AV nodal pathway on the parasympathetic innervation to the AV node in patients with AV nodal reentrant tachycardia (AVNRT), AV nodal conduction was evaluated following vagal stimulation by means of a phenylephrine bolus injection (200 micrograms) before and after RFCA in ten patients (mean age, 37 +/- 14 years). Nine patients with AV reentrant tachycardia (AVRT) due to a left free wall accessory pathway served as a control group (mean age of 37 +/- 12 years). Whereas no prolongation of the AH interval was observed in the AVNRT group following the phenylephrine bolus during sinus rhythm, despite a significant slowing in sinus rate, phenylephrine administration in AVRT patients was associated with both slowing of the sinus rate and prolongation of the AH interval. Following successful RFCA, the same responses were observed. To delineate the indirect effect of heart rate on AV conduction in response to the phenylephrine bolus, the AH interval was also measured during fixed atrial pacing. A marked prolongation of the AH interval occurred in both groups following phenylephrine administration. This prolongation was biphasic in 50% of AVNRT patients before ablation, suggesting a predominant effect of vagal stimulation on the fast AV nodal pathway. RFCA was associated with disappearance of discontinuous AV conduction in all but one patient with AVNRT. Vagal stimulation caused the same amount of AH interval prolongation as before RFCA in both study groups. In conclusion, patients with AVNRT have a preserved modulation of AV nodal conduction in response to vagal stimulation during sinus rhythm. In addition, vagal stimulation seems to exert a predominant effect on the fast AV nodal pathway. RFCA of the slow AV nodal pathway in patients with AVNRT does not cause detectable damage to the vagal innervation to the AV node.
为评估房室结折返性心动过速(AVNRT)患者行慢房室结径路射频导管消融(RFCA)对房室结副交感神经支配的潜在不良影响,在10例患者(平均年龄37±14岁)RFCA前后,通过静脉推注苯肾上腺素(200微克)进行迷走神经刺激后评估房室传导。9例因左侧游离壁旁路导致房室折返性心动过速(AVRT)的患者作为对照组(平均年龄37±12岁)。在窦性心律时,尽管窦性心率显著减慢,但AVNRT组静脉推注苯肾上腺素后未观察到AH间期延长,而AVRT患者静脉推注苯肾上腺素则与窦性心率减慢和AH间期延长有关。成功进行RFCA后,观察到相同的反应。为明确心率对静脉推注苯肾上腺素时房室传导的间接影响,在固定心房起搏时也测量了AH间期。两组患者静脉推注苯肾上腺素后AH间期均显著延长。消融前50%的AVNRT患者中这种延长呈双相性,提示迷走神经刺激对快房室结径路有主要影响。除1例AVNRT患者外,RFCA与所有患者间断性房室传导消失有关。两个研究组中,迷走神经刺激导致的AH间期延长与RFCA前相同。总之,AVNRT患者在窦性心律时对迷走神经刺激的房室传导调节功能保留。此外,迷走神经刺激似乎对快房室结径路有主要影响。AVNRT患者行慢房室结径路RFCA不会对房室结的迷走神经支配造成可检测到的损害。